SlidesetViral Hepatitis and Liver DiseaseVirological Approach - Small interfering RNA’s | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)View Slideset
SlidesetViral Hepatitis and Liver DiseaseVirological Approach - New Nucleoside Analogue & Capsid inhibition | Fabien Zoulim, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseVirological Approach - Assembly and Secretion Inhibitors | Tim Block, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseVirological Approach - CCC – DNA inhibition | Massimo Levrero, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseImmunomodulatory Agents - Therapeutic Vaccines | Kyong-Mi Chang, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseHow does HBV interact with the immune system? | Robert Thimme, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseAdaptive Immunity: - PDL Blockers | Mala Maini, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseHow to combine new treatments? Clinical approach | Marion Peters, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseCurrent Status of HBV Therapy | Pietro Lampertico, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseWhy do we need new treatments and what is our definition of cure? | Harry Janssen, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseHow to combine new treatments? Scientific approach | Jordan Feld, MD, MPHView Slideset
SlidesetViral Hepatitis and Liver DiseaseVirological Approach - Entry inhibition | Stephan Urban, PhDView Slideset
